Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJul 3, 2019Mitomycin Preservative Free IrrigationLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1420-2019Class IITerminatedJul 3, 2019Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1419-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1418-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1417-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1416-2019Class IITerminatedJul 3, 2019Droperidol Injectable Sterile SolutionLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1415-2019Class IITerminatedJul 3, 2019Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1414-2019Class IITerminatedJul 3, 2019ChlorproMAZINE HCL INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1413-2019Class IITerminatedJul 3, 2019Brilliant Blue Ophthalmic PF INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1412-2019Class IITerminatedJul 3, 2019Atropine Sulfate PF INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1411-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1453-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 1.5 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1452-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1451-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1450-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1449-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1448-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 1 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1447-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.5 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1446-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.25 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1445-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochoride Tablets 0.25 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1444-2019Class IITerminatedJun 26, 2019Pramipexole DihydrochlorideTablets 0.125 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1443-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.125 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1442-2019Class IITerminatedJun 26, 2019Anastrozole TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1441-2019Class IITerminatedJun 26, 2019ANASTROZOLE TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1440-2019Class IITerminatedJun 26, 2019Robafen DMCGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Preferred Pharmaceuticals, Inc · D-1410-2019Class IITerminatedJun 26, 2019Cetirizine Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1409-2019Class IITerminatedJun 26, 2019Cetirizine Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1408-2019Class IITerminatedJun 26, 2019Cetirizine HCL Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1407-2019Class IITerminatedJun 26, 2019Anastrozole TabletsGMP Deviations: Potential cross contamination due to cleaning procedure failure.American Health Packaging · D-1394-2019Class IIITerminatedJun 26, 2019QUIK-CARE Aerosol Foam Hand SanitizerIncorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.Ecolab Inc · D-1393-2019Class IIITerminatedJun 26, 2019MyorisanLabeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.Akorn Inc · D-1392-2019Class IIITerminatedJun 26, 2019Betamethasone Dipropionate Ointment USPFailed Impurities/Degradation SpecificationsTeligent Pharma, Inc. · D-1391-2019Class IITerminatedJun 26, 2019Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mgTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1390-2019Class IITerminatedJun 26, 2019Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release TabletsTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1389-2019Class IITerminatedJun 26, 2019Allergy Relief DTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1388-2019Class IITerminatedJun 26, 2019Allergy Relief DTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1387-2019Class IITerminatedJun 19, 2019Senna (sennosides 8.8 mg) Syrup 8 fl ozFailed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reportedGeritrex, LLC · D-1437-2019Class IITerminatedJun 19, 2019Senna (sennosides 8.8 mg) SyrupFailed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reportedGeritrex, LLC · D-1436-2019Class IITerminatedJun 19, 2019SevofluraneFailed Stability SpecificationsBaxter Healthcare Corporation · D-1435-2019Class IITerminatedJun 19, 2019Sn-Pyrophosphate KitLack of Processing Controls.Synthetopes Inc · D-1406-2019